Coherus Oncology, Inc. is rated a Buy driven by a promising clinical pipeline and undervaluation. Learn more about CHRS stock ...

AI and ML are transforming clinical trials by enhancing efficiency, reducing costs, and improving outcomes. Opportunities include understanding AI/ML fundamentals, optimizing trials, predicting ...

Bipolar Disorder, Digital Phenotyping, Multimodal Learning, Face/Voice/Phone, Mood Classification, Relapse Prediction, T-SNE, Ablation Share and Cite: de Filippis, R. and Al Foysal, A. (2025) ...

Edwards Lifesciences Corp. (EW) announced an update on their ongoing clinical study.Claim 70% Off TipRanks This Holiday SeasonUnlock hedge-fund level data and powerful investing tools for smarter, ...

Digital patient monitoring systems (DPMS) market refer to a broad spectrum of technologies designed to continuously monitor ...

Domestic cats have become increasingly important as companion animals, accompanied by growing concern from owners regarding their health and, consequently, ...

Objective This study aimed to explore health professionals’ perspectives on the management of preschool wheeze, including ...

AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.

WTX-124 initial Phase 1b expansion arm data showed 30% overall response rate as a monotherapy in a defined subset of post-ICI advanced or ...

Introduction Implementation of low-intensity, evidence-based psychological interventions can help meet the mental health and ...